One-two punch treatment knocks out acute myeloid leukaemia
08 May, 2024Researchers paired venetoclax, a current standard-of-care anticancer drug for acute myeloid leukaemia, with a STING agonist, an emerging class of immunotherapy drug.
Creating self-assembling capsules for drug delivery
07 May, 2024Scientists have created nanosized capsules that could be used to deliver drugs and messenger RNA (mRNA), a molecule that instructs cells to produce proteins.
Hybrid insulin pumps work well for type 1 diabetes
03 May, 2024Advanced hybrid closed loop (AHCL) insulin pumps are designed to constantly measure blood sugar levels, using specific algorithms to dose insulin and automatically keep blood sugar levels in check.
3D-printed films provide targeted liver cancer treatment
01 May, 2024Researchers have created drug-loaded, 3D-printed films that kill more than 80% of liver cancer cells while minimising the systematic toxicities of traditional chemotherapy.
Repurposed drugs show promise in heart muscle regeneration
26 April, 2024The FDA-approved medications, when given in combination, target two proteins that regulate the heart muscle's regeneration capabilities.
RNA-targeted therapy shows promise for childhood dementia
22 April, 2024Scientists have shown that a new RNA-targeted therapy can halt the progression of a specific type of childhood dementia in mice.
Oral UTI vaccine prevents infection for up to nine years
12 April, 2024An oral spray-based vaccine could help prevent recurrent urinary tract infections (UTIs) for up to nine years, offering a potential alternative to antibiotic treatments.
A solution for sleep apnoea could be right under your nose
09 April, 2024When used in a nasal spray, potassium channel blockers have the potential to increase the activity of the muscles that keep the upper airway open.
Creating a genetic medicine manufacturing ecosystem: part 5
18 March, 2024 by Peter Davis, ATA ScientificWhen it comes to the mission to democratise medicine, Australia has a material opportunity to affirm its destiny and be a global leader.
$50m grant to power Artificial Heart Frontiers Program
11 March, 2024The MRFF-funded Artificial Heart Frontiers Program will seek to develop and commercialise three key devices to treat the most common forms of heart failure.
Plasma treatment used to heal chronic wounds
29 February, 2024The treatment involves boosting the plasma activation of hydrogel dressings with a unique mix of different chemical oxidants that decontaminate and help heal chronic wounds.
Spider silk-inspired electrode wraps around tissues and organs
21 February, 2024Scientists have created a flexible electrode that wraps around muscles, nerves and hearts to deliver electrical stimulation to tissues or record electrical activity.
Bowel cancer drugs tested on tumour organoids
14 February, 2024A research team has grown tumour organoids in the lab, in order to predict what drugs will work for bowel cancer patients before they begin treatment.
Successful embryo transfer could save rhinos from extinction
29 January, 2024The successful embryo transfer and pregnancy of a southern white rhino allow researchers to safely move to the transfer of northern white rhino embryos.
Special contact lenses can diagnose glaucoma
24 January, 2024Researchers have developed a contact lens that can detect changes in eye pressure that signal possible glaucoma.
